» Authors » Melissa H Coleman

Melissa H Coleman

Explore the profile of Melissa H Coleman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 80
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Files D, Matthay M, Calfee C, Aggarwal N, Asare A, Beitler J, et al.
BMJ Open . 2022 Jun; 12(6):e060664. PMID: 35667714
Introduction: The COVID-19 pandemic brought an urgent need to discover novel effective therapeutics for patients hospitalised with severe COVID-19. The Investigation of Serial studies to Predict Your Therapeutic Response with...
2.
Coleman M, Aldrich J
Crit Care Clin . 2021 Sep; 37(4):851-866. PMID: 34548137
This review describes the management of mechanical ventilation in patients with acute respiratory distress syndrome, including in those with coronavirus disease 2019. Low tidal volume ventilation with a moderate to...
3.
De Rienzo A, Coleman M, Yeap B, Severson D, Wadowski B, Gustafson C, et al.
Cancers (Basel) . 2021 Feb; 13(3). PMID: 33540554
Sex differences in incidence, prognosis, and treatment response have been described for many cancers. In malignant pleural mesothelioma (MPM), a lethal disease associated with asbestos exposure, men outnumber women 4...
4.
Kue R, Temin E, Weiner S, Gates J, Coleman M, Fisher J, et al.
Prehosp Emerg Care . 2015 Feb; 19(3):399-404. PMID: 25665102
Introduction: Despite the resurgence of early tourniquet use for control of exsanguinating limb hemorrhage in the military setting, its appropriate role in civilian emergency medical services (EMS) has been less...
5.
De Rienzo A, Richards W, Yeap B, Coleman M, Sugarbaker P, Chirieac L, et al.
Clin Cancer Res . 2013 Mar; 19(9):2493-502. PMID: 23493352
Purpose: To develop a standardized approach for molecular diagnostics, we used the gene expression ratio bioinformatic technique to design a molecular signature to diagnose malignant pleural mesothelioma (MPM) from among...
6.
Coleman M, Bueno R
Surg Oncol Clin N Am . 2011 Oct; 20(4):757-67. PMID: 21986270
Complete surgical resection is the main therapy for early-stage non-small cell lung cancer. Survival rates remain, at best, 80% for stage IA, necessitating the development of effective systemic therapy. Several...
7.
Coleman M, Awad Z, Pomp A, Gagner M
Obes Surg . 2006 Jun; 16(6):770-2. PMID: 16756740
Small-bowel obstruction secondary to internal hernia is a known postoperative complication of laparoscopic Roux-en-Y gastric bypass (RYGBP). Petersen's defect is the most common site of postoperative internal herniation. The authors...